Litcius/Paper detail

ASP7266, a Novel Antibody against Human Thymic Stromal Lymphopoietin Receptor for the Treatment of Allergic Diseases

Mako Numazaki, Masaki Abe, Kaori Hanaoka, Emiko Imamura, Masashi Maeda, Akihiko Kimura, Jun Miyanohara, Tetsu Saito, Kazunori Arai, Hiroshi Suzuki, Yuji Saita

2021Journal of Pharmacology and Experimental Therapeutics15 citationsDOIOpen Access PDF

Topics & Concepts

Thymic stromal lymphopoietinImmunologyAntibodyStromal cellMedicinePharmacologyCancer researchImmune systemAsthma and respiratory diseasesIL-33, ST2, and ILC PathwaysAllergic Rhinitis and Sensitization
ASP7266, a Novel Antibody against Human Thymic Stromal Lymphopoietin Receptor for the Treatment of Allergic Diseases | Litcius